Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect Cognitive Behavioral Therapy (CBT) in the Treatment of Anxiety and Depression in Patients With Inflammatory Bowel Disease

NCT05377840 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05377840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect Cognitive Behavioral Therapy (CBT) in the Treatment of Anxiety and Depression in Patients With Inflammatory Bowel Disease
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
July 5, 2022
Completion date
June 6, 2026
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis (uc)